MDS Podcast

International Parkinson and Movement Disorder Society
undefined
Nov 1, 2019 • 0sec

The treatment of upper limb tremor with botulinum toxin: An individualized approach

Dr. Sara Schaefer discusses with Dr. Jordan Kamel the role of botulinum toxin in the treatment of refractory upper limb tremor, and his center's tailored approach to provide relief for these patients. Read the article
undefined
Oct 24, 2019 • 0sec

Dystonia | Congress 2019

As part of the MDS Congress 2019 Special Issue, Dr. Sara Schaefer interviews Dr. Hyder Jinnah about notable research in dystonia and activities of the MDS Dystonia Study Group.
undefined
Oct 24, 2019 • 0sec

Neuroimaging in movement disorders | Congress 2019

As part of the MDS Congress 2019 Special Issue, Dr. Sara Schaefer interviews Dr. Antonio Strafella about the emerging research in neuroimaging in movement disorders and plans to establish a centralized database for neuroimaging in atypical parkinsonisms.
undefined
Oct 23, 2019 • 0sec

Huntington's disease | Congress 2019

As part of the MDS Congress 2019 Special Issue, Dr. Schaefer and Dr. Sarah Tabrizi discuss the evolving research in disease-modifying therapies for Huntington's Disease, and what may come next. Read the article
undefined
Oct 18, 2019 • 0sec

Introduction and functional movement disorders | Congress 2019

Did you miss the MDS Congress in Nice, or do you just want an overview of highlights from the International Congress as well as a look forward at new ventures? Dr. Schaefer introduces the MDS Congress 2019 special issue, which features interviews with experts in various fields of movement disorders at the MDS Congress 2019. In this first issue, Dr. Sara Schaefer interviews Dr. Kathrin LaFaver about notable research in functional movement disorders, activities of the MDS Functional Movement Disorders Study Group, and more.
undefined
Oct 18, 2019 • 0sec

Education at the MDS | Congress 2019

As part of the MDS Congress 2019 Special Issue, Dr. Sara Schaefer interviews Dr. Ronald Postuma about all of the educational offerings through the MDS, as well as new projects of the MDS Education Committee.
undefined
Oct 14, 2019 • 0sec

Definition and characteristics of early onset PSP: A different disease?

In this interview with Dr. Edwin Jabbari, we highlight the results of his study on the definition and genetic and neuropathological characteristics of early onset progressive supranuclear palsy. The full study is available on the September 2019 issue of the Movement Disorders journal. Read the article
undefined
Aug 30, 2019 • 0sec

MDS PSP criteria in practice: From clinical phenotyping to pathological diagnosis

Dr. Farwa Ali discusses with Dr. Sara Schaefer the results of her study on the use of the MDS criteria for PSP with the MAX rules and their clinical implications, as well as the challenges of the phenotype variability of this disease in clinical practice and research. Read the article
undefined
Aug 6, 2019 • 0sec

Iron imaging of substantia nigra in Parkinson's disease: A possible biomarker?

Dr. Niels Bergsland discusses with Dr. Michele Matarazzo the results of the article he recently published in the Movement Disorders journal on longitudinal iron imaging in the substantia nigra in PD and in its different regions. Read the article
undefined
Jun 28, 2019 • 0sec

Patient vs. care partner assessment of cognitive disability in Parkinson's: Who's more accurate?

Benjamin Deck discusses with Dr. Schaefer the article he recently published in the Movement Disorders Clinical Practice on the patient vs. care partner assessment of cognition in Parkinson's disease. Read the article

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app